Загрузка...
Neoadjuvant Chemotherapy Considerations in Triple-Negative Breast Cancer
The optimal neoadjuvant chemotherapy (NACT) regimen in triple-negative breast cancer (TNBC) has not been clearly defined. Achieving a pathologic complete response (pCR) provides important prognostic information, and, especially in TNBC, is considered a surrogate endpoint for event-free survival. Thu...
Сохранить в:
| Опубликовано в: : | J Target Ther Cancer |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865448/ https://ncbi.nlm.nih.gov/pubmed/29577076 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|